Cargando…

Nomogram development and external validation for predicting overall survival and cancer-specific survival in patients with primary retroperitoneal sarcoma: a retrospective cohort study

BACKGROUND: Primary retroperitoneal sarcoma (RPS) comprises over 70 histologic subtypes, yet there are limited studies that have developed prognostic nomograms for RPS patients to predict overall survival (OS) and cancer-specific survival (CSS). The objective of this study was to construct prognosti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Jialiang, Zhuang, Aobo, Xia, Xiaogang, Miao, Fenglin, Wang, Zhao, Kong, Xu, Ren, Yantao, Ma, Yuan, Lin, Zhenhang, Lu, Weiqi, Li, Wengang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620366/ https://www.ncbi.nlm.nih.gov/pubmed/37910291 http://dx.doi.org/10.1007/s12672-023-00804-1

Ejemplares similares

Development and Validation of a Nomogram for Predicting Recurrence-Free Survival of Surgical Resected Retroperitoneal Liposarcoma
por: Zhuang, Aobo, et al.
Publicado: (2021)

Nomogram predicting overall survival after surgical resection for retroperitoneal leiomyosarcoma patients
por: Zhuang, Aojia, et al.
Publicado: (2023)

Development and Validation of the Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Patients With Synovial Sarcoma
por: Song, Zhengqing, et al.
Publicado: (2022)

Development and validation of a nomogram for predicting morbidity in surgically resected primary retroperitoneal sarcoma
por: Zhuang, Aobo, et al.
Publicado: (2023)

Sarcopenia is associated with worse surgical complications but not relapse-free survival and overall survival in patients with retroperitoneal liposarcoma
por: Zhao, Mingkun, et al.
Publicado: (2022)

Construction and validation of a nomogram to predict overall survival in patients with breast sarcoma
por: Cheng, Yixin, et al.
Publicado: (2022)

Tumor grade and symptoms at presentation are survival risk factors in Chinese patients with primary retroperitoneal sarcoma
por: Zhuang, Aobo, et al.
Publicado: (2022)

Identification of a clinical web-based nomogram to predict overall survival in elderly retroperitoneal sarcoma patients: A population-based study
por: Zheng, Honghong, et al.
Publicado: (2022)

Prognostic Factors and Nomogram Construction for First Local Recurrent Retroperitoneal Sarcoma Following Surgical Resection: A Single Asian Cohort of 169 Cases
por: Zhuang, Aobo, et al.
Publicado: (2022)

Development and external validation of a nomogram predicting overall survival after curative resection of colon cancer
por: Wang, Shuanhu, et al.
Publicado: (2021)

Development and Validation of Novel Nomograms for Predicting Specific Distant Metastatic Sites and Overall Survival of Patients With Soft Tissue Sarcoma
por: Tu, QiHao, et al.
Publicado: (2021)

Evaluation of Preoperative Chemotherapy or Radiation and Overall Survival in Patients With Nonmetastatic, Resectable Retroperitoneal Sarcoma
por: Ma, Sung Jun, et al.
Publicado: (2020)

Development and Validation of a Nomogram for Predicting Overall Survival in Pancreatic NeuroendocrineTumors()()
por: Miao, Dong-liu, et al.
Publicado: (2018)

Development and External Validation of a Nomogram for Predicting Overall Survival in Stomach Cancer: A Population-Based Study
por: Ji, Haonan, et al.
Publicado: (2021)

Unplanned reoperation after resection of retroperitoneal sarcoma: experience based on a high-volume sarcoma center
por: Zhuang, Aobo, et al.
Publicado: (2022)

Development and Validation of an Individualized Nomogram for Predicting Overall Survival in Patients With Typical Lung Carcinoid Tumors
por: Dong, Shenghua, et al.
Publicado: (2020)

Development and validation of a nomogram to predict the overall survival of patients with neuroblastoma
por: Liu, Qinglin, et al.
Publicado: (2020)

Survival nomogram for medulloblastoma and multi-center external validation cohort
por: Li, Xiang, et al.
Publicado: (2023)

Multivisceral resection of primary multifocal retroperitoneal sarcomas: a retrospective study from a high-volume sarcoma center
por: Zhuang, Aobo, et al.
Publicado: (2023)

A nomogram for predicting overall survival in patients with Ewing sarcoma: a SEER-based study
por: Zhou, Zhenggang, et al.
Publicado: (2020)

Establishment of an orthotopic perirenal space xenograft mouse model of retroperitoneal sarcoma
por: Xie, Fu'an, et al.
Publicado: (2021)

Overall survival nomogram and relapse-related factors of clear cell sarcoma of the kidney: A study based on published patients
por: Zhang, Yuan, et al.
Publicado: (2022)

A novel nomogram model to predict the overall survival of patients with retroperitoneal leiomyosarcoma: a large cohort retrospective study
por: Huang, Chao, et al.
Publicado: (2022)

Development and external validation of a nomogram for predicting the overall survival of patients with stage II nasopharyngeal carcinoma after curative treatment
por: He, Sha-Sha, et al.
Publicado: (2019)

Development and external validation of a nomogram to predict overall survival following stereotactic body radiotherapy for early-stage lung cancer
por: Baker, Sarah, et al.
Publicado: (2020)

External Validation of a Nomogram Developed for Predicting Overall Survival in Gastric Cancer Patients with Insufficient Number of Examined Lymph Nodes
por: Kubat, Mehmet, et al.
Publicado: (2022)

Development and Validation of Nomograms to Predict Overall Survival and Cancer-Specific Survival in Patients With Pancreatic Adenosquamous Carcinoma
por: Yang, Zhen, et al.
Publicado: (2022)

A nomogram to predict overall survival for biliary tract cancer
por: Song, Wei, et al.
Publicado: (2018)

Development and validation of a pretreatment nomogram to predict overall survival in gastric cancer
por: Bando, Etsuro, et al.
Publicado: (2020)

A novel and validated nomogram to predict overall survival for gastric neuroendocrine neoplasms
por: Zhang, Sheng, et al.
Publicado: (2019)

Development and Validation a Nomogram for Predicting Overall Survival in Patients With Intrahepatic Cholangiocarcinoma
por: Yuan, Chen, et al.
Publicado: (2021)

Development and validation of a nomogram for predicting the overall survival of patients with testicular cancer
por: Yu, Haohui, et al.
Publicado: (2023)

Prognostic Factor Analysis and Nomogram Construction of Primary Retroperitoneal Liposarcoma: A Review of 10 Years of Treatment Experience in a Single Asian Cohort of 211 Cases
por: Zhuang, Aobo, et al.
Publicado: (2022)

An Efficient Nomogram to Predict Overall Survival of Patients with Pediatric Ewing’s Sarcoma: A Population-Based Study
por: Dai, Ke-Na, et al.
Publicado: (2021)

Development and external validation of nomograms for predicting individual survival in patients with ovarian clear cell carcinoma
por: Liu, Xiaoshi, et al.
Publicado: (2023)

Development and validation of a prognostic nomogram for predicting overall survival in patients with primary bladder sarcoma: a SEER-based retrospective study
por: Li, Shijie, et al.
Publicado: (2021)

External validation and newly development of a nomogram to predict overall survival of abiraterone-treated, castration-resistant patients with metastatic prostate cancer
por: Yang, Yun-Jie, et al.
Publicado: (2018)

The impact of previous cancer on overall survival of bladder cancer patients and the establishment of nomogram for overall survival prediction
por: Wang, Zhengquan, et al.
Publicado: (2020)

Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients with Stage IV colorectal cancer
por: Zhang, Jieyun, et al.
Publicado: (2019)

Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma
por: Chen, Qian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vgkq5bid88mk4123amua7g3elm